Saturday, May 21, 2016 5:12:36 PM
I'm really sorry the stock is sitting this low. The Company has a diminishing shareholder base. Their supporters have been the ones that have been hurt the most.
What Dan fails to see that his post of: " focus on getting one single successful story out to the general public, either L or D, which doesn't matter as long as the company can make it happen" can't occur if they don't figure out a way to have their DCVAX platform survive in the event of L clinical failure. There needs to be demand on the stock in order for NW Bio to raise money to fund L + D trials. But instead of demand, shareholders are running scared. With each financing it is taking more and more shares to raise the same $10 million figure. It is now trading like a penny stock because the market is being convinced, at least temporarily, that L will fail. Right now, Direct is not be considered in the Company's market cap valuation, at all. If NW Bio does not line up good news soon, then the future raises they secure will end up becoming more and more toxic. The Company recognizes that if they are able to line up "official" DCVax platform + CI combination studies, they will be well received. It will help to bring Direct back into the conversation. If the company secures a CI; and, if they work on subsequent steps to get INDs some of their scared investors might return. Demand for their stock will grow. They then will be able to raise money to fund "pending" Direct trials. A clean COI bill of health, and Woodford will consider buying shares (funding), particularly if they license a CI. They get they need that money. However, these combination negotiations need to be finalized soon. In the event that L fails, the company will be stopped in their capital raise tracks, if they don't have a market buy-in on another viable study (one that is perceived to have a great chance of success) within their pipeline. And so yes, at this point, it makes strategic sense that the company plan for both success and failure of L. Aligning with a CI now is the best shot they have at avoiding bankruptcy if L fails. And if it's successful, the stock won't be shorted as heavily as it is now.
As for Dan's other point, of course, they want to keep spending down; but, that goes without saying.
Recent NWBO News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/03/2024 08:01:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 08:01:24 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2024 09:06:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2024 08:30:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 02:42:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/30/2024 11:49:38 PM
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
FEATURED North Bay Resources Announces Federal (MSHA) Approval of Mt. Vernon Gold Mine Operational Plan and Commencement of Production, Sierra County, California • Oct 21, 2024 9:00 AM
Hydromer, Inc. Announces the Restructuring and Formation of World-Class Research and Development Division to Drive Innovation and New Product Development • HYDI • Oct 21, 2024 9:00 AM
SANUWAVE Announces Reverse Stock Split, Note and Warrant Exchange, and PIPE Offering • SNWV • Oct 18, 2024 9:31 AM
Vocodia Addresses Recent Stock Price Movement and Future Strategic Partnerships • VHAI • Oct 18, 2024 9:00 AM
Mass Megawatts Announces the Start of an Online Discount Solar Energy Equipment Business with Revenue Recognized for the First Time Since Year 2010 in this Fiscal Quarter • MMMW • Oct 18, 2024 7:32 AM
Unitronix Corp Advances DeFi Innovation with Tokenized Real-World Assets Integration • UTRX • Oct 17, 2024 7:38 AM